Scancell Holdings Plc (LON:SCLP) fell 8.6% on Wednesday . The company traded as low as GBX 15.58 ($0.22) and last traded at GBX 15.63 ($0.22). 196,134 shares traded hands during trading, a decline of 63% from the average session volume of 536,966 shares. The stock had previously closed at GBX 17.10 ($0.24).
The stock has a market capitalization of $56.20 and a price-to-earnings ratio of -1,525.00.
TRADEMARK VIOLATION NOTICE: “Scancell (SCLP) Shares Down 8.6%” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://ledgergazette.com/2018/03/14/scancell-sclp-shares-down-8-6.html.
Scancell Company Profile
Scancell Holdings plc is a biopharmaceutical company focused on the cancer therapeutics market. The Company’s principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer. The Company is developing a pipeline of immunotherapies for the treatment of cancer based on its ImmunoBody and Moditope platforms.
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.